<DOC>
	<DOC>NCT00772382</DOC>
	<brief_summary>The primary objective of this study is to demonstrate the long-term safety and tolerability of MCI-196 in the subjects with stage V chronic kidney disease on dialysis with hyperphosphatemia. The secondary objective of this study is to assess the long-term efficacy of flexible doses of MCI-196.</brief_summary>
	<brief_title>Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Bile Acids and Salts</mesh_term>
	<criteria>Male or female, and is &gt;=18 years old Stable hemodialysis or peritoneal dialysis Subjects have stable phosphate control Subjects on stabilized phosphorus diet Subjects undergoing regular dialysis treatment Females and of childbearing potential have a negative serum pregnancy test Male subjects must agree to use appropriate contraception Current clinically significant medical comorbidities, which may substantially compromise subject safety, or expose him/her to undue risk, or interfere significantly with study procedures and which, in the opinion of the Investigator, makes the subject unsuitable for inclusion in the study serum albumin level &lt; 3.0g/L PTH level &gt; 1000pg/mL Hemoglobin level &lt; 8mg/dL A History of significant gastrointestinal motility problems Biliary obstruction or proven liver dysfunction A positive test for HIV 1 and 2 antibodies A history of substance or alcohol abuse within the last year Seizure disorders A history of drug or other allergy using cholestyramine, colestipol or colesevelam Schedule to receive a kidney transplant within the next 6 months Participation in a clinical study with any experimental medication in the last 30 days or an experimental biological product within the last 90 days prior to signing of informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Hyperphosphatemia</keyword>
	<keyword>Phosphate binder</keyword>
</DOC>